0000899243-20-011919.txt : 20200504
0000899243-20-011919.hdr.sgml : 20200504
20200504182125
ACCESSION NUMBER: 0000899243-20-011919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200501
FILED AS OF DATE: 20200504
DATE AS OF CHANGE: 20200504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fishman Corey N.
CENTRAL INDEX KEY: 0001553594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19879
FILM NUMBER: 20846286
MAIL ADDRESS:
STREET 1: DURATA THERAPEUTICS, INC.
STREET 2: 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-01
0
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001553594
Fishman Corey N.
C/O BIOSPECIFICS TECHNOLOGIES CORP.
2 RIGHTER PKWY, DELAWARE CORP. CENTER II
WILMINGTON
DE
19803
1
0
0
0
Stock Option (Right to Buy)
55.63
2020-05-01
4
A
0
6000
0.00
A
2030-05-01
Common Stock
6000
6000
D
The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
The stock options vest in three equal installments over the three-year period following the date of grant.
/s/ Corey Fishman by Carl A. Valenstein, attorney- in-fact
2020-05-04